The Value Agenda for The Netherlands
To stimulate the generation of actions to take VBHC implementation to the next level, The Decision Group partners with pioneering organizations in the VBHC field to organize a yearly VBHC Working Session with 25 key decision makers in Dutch health care. The Working Session has one primary goal: to accelerate VBHC implementation in the Netherlands by creating the right climate for VBHC initiatives to flourish.
This year, the Working Session resulted in 5 main accelerators to be able to generate patient value by making data accessible, which can be found in the Value Agenda report of 2023. Click here to read the full report, or check out the aftermovie below.
Value Agenda Working Session 2023 – News
This year, The Decision Group, Amgen, and Roche organized the Value Agenda NL Working Session 2023 together with key decision-makers in the Dutch healthcare sector. After two inspiring presentations with examples from practice by Hans Paalvast (Zorginstituut Nederland) and Pieter de Bey (Santeon), this group of professionals delved deeper into the topic of Health Data & IT, focusing on the insights and evidence required from data on a national level to collectively take the next step toward patient-centered care.
The Value Agenda NL Working Session 2023 took place on the 26th of June, 2023. All information about this year’s VBHC Working Session can be found in this section of the website and on our Linkedin.
About the project
There is a commitment to move towards VBHC among health care providers in the Netherlands. A number of excellent initiatives promoting VBHC have already been developed. The next challenge is to implement these practices on a large scale.
Since the appearance of the first Value Agenda for the Netherlands in 2017, much progress has been made on the agenda and the agenda undeniably has had a huge positive impact on patient value.
65+
Leading organizations affiliated
110+
Key decision makers involved
280.000+
International reach
The Value Agenda over the years
In 2017 Harvard professor Michael Porter, founding father of VBHC, set out the Value Agenda for the Netherlands. In 2018, Dr. Bohmer and Prof. Cripps carried the torch, setting the Value Agenda for the Netherlands for 2018, emphasizing the need for leadership and culture. During the third edition of the VBHC Working Session in 2019, founding mother of VBHC Prof. Elizabeth Teisberg inspired and helped to formulate the next actions to stimulate the right climate and therefore should be on the Value Agenda for the Netherlands. The fourth edition of the VBHC Working Session in 2021 marked the turning point, where we started to move the conversation towards paying for value. With a multidisciplinary group of professionals and leaders in healthcare in The Netherlands, the Working Session resulted in new insights in the controversial topic that paying for value is.
The sixth edition of the VBHC Working Session took place on the 26th of June 2023. The group set of health care professionals generate patient value by making data accessible and formulated 5 actions to better patient outcomes by improved data availability. The Working Session resulted in new insights, recommendations and (pre-)conditions, to be found in the Value Agenda 2023 report below.
Report
Partners
The Decision Group is proud to partner with Amgen and Roche, two leading healthcare organizations that are pioneering in value-based healthcare initiatives. Amgen creates value by focusing on the needs of patients, serving them by transforming science and biotechnology into therapies that restore health and save lives. At Roche, personalised healthcare is a key area of focus, combining pioneering science, data, analytics and technology to advance new discoveries and improve patients’ lives. It is a great opportunity to work together with a team of experienced partners that strive to keep moving forward the Value Agenda NL.
